Trials / Completed
CompletedNCT05055570
Angiotensin II Pathway and Postoperative Hypoxemia
The Mechanism Research of Angiotensin II Pathway and Postoperative Hypoxemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 88 (actual)
- Sponsor
- Beijing Anzhen Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Acute type A aortic dissection is often accompanied by postoperative hypoxemia, the cause of which is not fully understood. Angiotensin II is an important component of the renin-angiotensin system (RAS), which has been suggested to be involved in the development of aortic dissection and pulmonary inflammation.The purpose of this study was to investigate the role and mechanism of angiotensin II pathway in postoperative hypoxemia after acute type A aortic dissection, and to provide reference for clinical application
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | No intervention |
Timeline
- Start date
- 2021-08-12
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
- First posted
- 2021-09-24
- Last updated
- 2024-01-26
- Results posted
- 2024-01-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05055570. Inclusion in this directory is not an endorsement.